Regenxbio (RGNX) Return on Capital Employed Growth (5y) (2020 - 2025)
Regenxbio (RGNX) Return on Capital Employed Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,150.00 |
| Sep 30, 2025 | -1,163.00 |
| Jun 30, 2025 | -214.00 |
| Mar 31, 2025 | -876.00 |
| Dec 31, 2024 | -2,822.00 |
| Sep 30, 2024 | -3,392.00 |
| Jun 30, 2024 | -3,102.00 |
| Mar 31, 2024 | -4,433.00 |
| Dec 31, 2023 | -7,398.00 |
| Sep 30, 2023 | -6,635.00 |
| Jun 30, 2023 | -6,764.00 |
| Mar 31, 2023 | -5,815.00 |
| Dec 31, 2022 | 393.00 |
| Sep 30, 2022 | 5,285.00 |
| Jun 30, 2022 | 5,021.00 |
| Mar 31, 2022 | 5,481.00 |
| Dec 31, 2021 | 5,676.00 |
| Sep 30, 2021 | -214.00 |
| Jun 30, 2021 | 165.00 |
| Mar 31, 2021 | -338.00 |